Literature DB >> 27352262

Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusion.

Mireille Crampe1, Jennifer Garry2, Stephen E Langabeer3, Philip T Murphy2.   

Abstract

Entities:  

Keywords:  Chronic myeloid leukaemia; Imatinib; Intolerance; Nilotinib; e19a2

Mesh：

Substances：

Year:  2016        PMID： 27352262     DOI： 10.1016/j.hemonc.2016.05.007

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


× No keyword cloud information.
  1 in total

1.  Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Authors:  Nuno Cerveira; Rosa Branca Ferreira; Susana Bizarro; Cecília Correia; Lurdes Torres; Susana Lisboa; Joana Vieira; Rui Santos; Fernando Campilho; Carlos Pinho Vaz; Luís Leite; Manuel R Teixeira; António Campos
Journal:  BMC Cancer       Date:  2018-12-07       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.